Chad Oh - 19 Mar 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Alexander Wilson as attorney-in-fact for Chad Oh
Issuer symbol
AEON
Transactions as of
19 Mar 2024
Net transactions value
$0
Form type
4
Filing time
21 Mar 2024, 19:48:02 UTC
Previous filing
24 Jul 2023
Next filing
04 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +86,720 $0.000000 86,720 19 Mar 2024 Common Stock 86,720 $14.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.